Na Lu
Impact in
- Pharmacology top 0.2%
- Flavonoids in Medical Research
- Synthesis of Organic Compounds
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Natural product bioactivities and synthesis 22
- Cell death mechanisms and regulation 14
- Angiogenesis and VEGF in Cancer 12
- Pharmacology 72
- Flavonoids in Medical Research 46
- Synthesis of Organic Compounds 17
- Co-authors
- Qinglong Guo (115 shared papers)Qidong You (63 shared papers)Qi Qi (31 shared papers)Zhiyu Li (45 shared papers)Yong Yang (23 shared papers)Li Zhao (22 shared papers)Yun Ling (15 shared papers)Hong-Yan Gu (16 shared papers)
- Journals
- Molecular Carcinogenesis (8 papers)Oncotarget (8 papers)Cancer Letters (8 papers)Toxicology (7 papers)PLoS ONE (6 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Na Lu
198 papers receiving 7.8k citations
Na Lu's Hit Papers
Peers
Comparison fields: 5 of 132
- Pharmacology 1.8k
- Cancer Research 1.3k
- Toxicology 192
- Molecular Biology 3.8k
- Oncology 1.3k
Countries citing papers authored by Na Lu
This map shows the geographic impact of Na Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Lu more than expected).
Fields of papers citing papers by Na Lu
This network shows the impact of papers produced by Na Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Lu. The network helps show where Na Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Na Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 201 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Application of Ferroptosis in Diseases Hit paper breakdown → | 2020 | 337 |
| 2 | 2018 | 296 | |
| 3 | 2011 | 238 | |
| 4 | 2007 | 211 | |
| 5 | 2009 | 173 | |
| 6 | 2010 | 169 | |
| 7 | 2007 | 151 | |
| 8 | 2015 | 132 | |
| 9 | 2013 | 114 | |
| 10 | 2014 | 108 | |
| 11 | 2008 | 95 | |
| 12 | 2013 | 91 | |
| 13 | 2016 | 90 | |
| 14 | 2007 | 89 | |
| 15 | 2008 | 85 | |
| 16 | 2017 | 84 | |
| 17 | 2018 | 84 | |
| 18 | 2009 | 83 | |
| 19 | 2013 | 82 | |
| 20 | 2020 | 82 |
About Na Lu
Na Lu is a scholar working on Molecular Biology, Pharmacology, Oncology, Cancer Research and Plant Science, having authored 201 papers that have together received 7.9k indexed citations. Recurring topics across this work include Flavonoids in Medical Research (46 papers), Natural Compound Pharmacology Studies (23 papers), Natural product bioactivities and synthesis (22 papers), Cancer-related Molecular Pathways (21 papers), Cancer, Hypoxia, and Metabolism (18 papers), Synthesis of Organic Compounds (17 papers), Cell death mechanisms and regulation (14 papers) and Angiogenesis and VEGF in Cancer (12 papers). The work is most often cited by research in Pharmacology (1.8k citations), Cancer Research (1.3k citations), Toxicology (192 citations), Molecular Biology (3.8k citations) and Oncology (1.3k citations). Na Lu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Qinglong Guo, Qidong You, Qi Qi, Zhiyu Li, Yong Yang, Li Zhao, Yun Ling, Hong-Yan Gu, Xiuming Song and Qinsheng Dai. Their work appears in journals such as Molecular Carcinogenesis, Oncotarget, Cancer Letters, Toxicology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.